INMB
INmune Bio Inc.
$2.03
-$0.06(-2.87%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$57.42M
Volume
541.37K
52W Range
$1.89 - $11.64
Target Price
$9.65
EPS Estimates Overview
| Current Quarter | $-0.31 | Next Quarter | $-0.31 |
| Current Year | $-1.34 | Next Year | $-1.29 |
| QoQ Growth | +0.0% | YoY Growth | +3.7% |
| 3Y EPS CAGR | -2.9% | Target Price | $9.65 |
| Consensus | Buy | Upside | +375.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | INMB | $2.03 | -2.9% | 541.37K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |